|
|
![]() |
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
|||||||||||||||||||||||||||||||||||||||||||||
| Sponsored by: |
Wake Forest University |
| Information provided by: | Wake Forest University |
| ClinicalTrials.gov Identifier: | NCT00654355 |
Purpose
The purpose of this research study is to better understand how the study drug works when people use it to treat atopic dermatitis.
| Condition | Intervention | Phase |
|
Atopic Dermatitis |
Drug: tacrolimus ointment |
Phase IV |
| ChemIDplus related topics: | Tacrolimus Tacrolimus anhydrous |
| Study Type: | Interventional |
| Study Design: | Treatment, Non-Randomized, Open Label, Single Group Assignment |
| Official Title: | Measuring Adherence to Topical Therapy in Children With Atopic Dermatitis and the Impact of a Return Visit |
| Estimated Enrollment: | 30 |
| Study Start Date: | April 2008 |
| Estimated Primary Completion Date: | September 2008 (Final data collection date for primary outcome measure) |
To evaluate adherence to topical therapy using adherence data collected by the MEMS cap (Medication Electronic Monitoring System) in pediatric patients with atopic dermatitis (AD) and the impact of a return visit.
Eligibility
| Ages Eligible for Study: | 2 Years to 15 Years |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Exclusion Criteria:
Contacts and Locations| Contact: Susie Dowd | 336-716-3775 | sdowd@wfubmc.edu |
| United States, North Carolina | |||||
| Dept of Dermatology, WFUHS | |||||
| Winston Salem, North Carolina, United States, 27157 | |||||
| Contact: Adele Clark, PA-C 336-716-3775 adclark@wfubmc.edu | |||||
| Principal Investigator: Steve R Feldman, MD, PHD | |||||
| Wake Forest University |
| Principal Investigator: | Steve Feldman, MD, PHD | WFUHS |
More Information
| Responsible Party: | Wake Forest University Health Sciences ( Dr .Steve Feldman ) |
| Study ID Numbers: | 00002300, contract #32417 |
| First Received: | April 2, 2008 |
| Last Updated: | April 7, 2008 |
| ClinicalTrials.gov Identifier: | NCT00654355 |
| Health Authority: | United States: Institutional Review Board |
|
|
|
|